GlassScriptPrepare for your visit
Daniel F King
Pediatrics · Clackamas, OR · NPI 1619243375
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,325.67
in general payments reported to CMS, 2019-2025 · $219 in 2025
The $219 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Who reported paying
General payments only, top 6 by amount.
- Sanofi Pasteur INC. $257.14
- Ironshore Pharmaceuticals INC. $180.37
- Takeda Pharmaceuticals U.S.A., INC. $162.34
- Corium, LLC $126.44
- Glaxosmithkline, LLC. $102.91
- Collegium Pharmaceutical, INC. $89.06
Drugs and devices associated with these payments
Jornay Pm Azstarys Beyfortus Grastek Odactra Ragwitek Bexsero Menquadfi Tzield Impella Neffy Vaxelis
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Daniel King listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1379871/daniel-f-king